Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Business Wire
Final 2025 global cohort onboarding, with applications now open for 2026 WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort announced in April 2025, the program provides early-stage biotechnology pioneers with access to extensive scientific and commercial expertise, as well as a comprehensive ecosystem of discovery, development, and manufacturing capabilities, to expedite the development of technologies and life-changing therapies for patients in need.“The CIP’s success shows how effectively it attracts top talent and promotes innovation,” said Kerstin Dolph, Corporate Senior Vice President of Global Manufacturing, Charles River. “By establishing a strong foundation for commercial viability, the CIP is helping participants advance life-saving therapeutics and transform innovative ideas into real-world
Show less
Read more
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort [Yahoo! Finance]Yahoo! Finance
- What Charles River Laboratories International (CRL)'s Strengthening DSA Bookings Trend Means For Shareholders [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories International (NYSE:CRL) was given a new $185.00 price target on by analysts at Morgan Stanley.MarketBeat
- HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
CRL
Earnings
- 11/5/25 - Beat
CRL
Sec Filings
- 12/3/25 - Form 8-K
- 11/17/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- CRL's page on the SEC website